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Abstract: 
Title: Culturally Targeted Decision Aid Use in Intention to Complete Colorectal Cancer 
Screening among African American Women 
Purpose: African American (AA) women experienced approximately 41% more deaths related 
to Colorectal Cancer (CRC) than White women in 2016. Provider recommendation has been a 
positive predictor of screening behavior. Along with provider recommendation, decision aids 
(DAs) can be useful tools to decrease health disparities and increase screening rates in racial, 
sex, and gender minorities. The purpose of the project is to determine if the use of DAs along 
with provider recommendation improve intention to complete CRC screening. 
Method: 21 AA women ages 45-75 years where recruited from a primary care office and asked 
to complete a 5 question survey gauging intention to complete CRC screening. They then viewed 
a culturally targeted DA regarding CRC screening. After viewing the DA, they completed the 
same 5-question survey regarding intention to complete CRC screening.  
Results: Twenty-one AA women aged 47-69 years completed the project. A Wilcoxon Signed 
rank test was conducted to evaluate the changes in intentions following of the culturally targeted 
DA intervention on AA women’s intention to complete CRC screening. Level of intention to 
complete screening did not differ significantly from the pre (M rank=8.44) to the post 
intervention group (M rank=9.50) where the sum of the ranks was 67.50 and 85.50 respectively 
and z=.666. 
Conclusion: Though the study did not show statistical significance in intention to complete 
screening, it did seem to increase knowledge of CRC screening. Addressing social issues and 
bringing awareness to the AA community about CRC screening is imperative to reduce 
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morbidity and mortality related to CRC. More research is needed on the use of decision aids 
specifically targeting high-risk populations such as African American women.  
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Decision Aid Use in Improving Intention to Perform Colorectal Cancer Screening among 
African American Women 
Colorectal Cancer (CRC) is the third most diagnosed cancer in the United States and the 
third leading cause of cancer related mortality in the United States (American Cancer Society, 
2016).  The American Cancer Society (2017) estimated that 95,520 new cases of colon cancer 
and 39,910 new cases of rectal cancer would occur in 2017. The incidence of mortality and 
morbidity among African Americans is higher than that of Whites. AAs have the shortest 
survival and overall highest death rates of CRC (Williams et.al, 2016).  According to the 
American Cancer Society (2017), African American women experienced approximately 41% 
more deaths than White women in 2016 accounting for nearly 8,550 deaths. This is a major 
concern because most deaths related to CRC are preventable by early screening. 
 African Americans have lower rates of screening for CRC cancer (Blumenthal, Smith, 
Majetta & Alema-Mensah, 2010, May, Whitman, Varlyguina, Bromley & Spiegel, 2015, 
Purmell, et al, 2008). Many factors attributing to lower screening rates among African American 
women are found in current literature.  Lack of insurance, lack of provider recommendation for 
CRC screening, lack of understanding of CRC procedures, and a lack of culturally targeted 
materials to educate this population are some reasons noted in reviewing the literature 
(Blumenthal, et.al, 2010, Hoffman, et.al, 2017). 
The use of culturally targeted decision aids to influence willingness to complete 
colorectal cancer screening among African Americans holds promise (Hoffman, et. al, 2017).  
Use of decision aids in minority patients, can be useful, tools to decrease health disparities in 
racial, sex, and gender minorities (Nathan, Marshall, Cooper & Haung, 2016).  In a systematic 
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review, culturally tailored aids had a seemingly greater impact on clinical decisions than those 
that were not tailored (Nathan, et. al, 2016).  
 The overall goal of this Doctor of Nursing Practice (DNP) project is to perform a pilot 
study comparing the effectiveness of provider recommendation for CRC screening in African 
American (AA) women ages 45-75, to the use of a culturally targeted educational decision aide 
(DA’s) in conjunction with provider recommendation.  
Background/Significance 
Colorectal cancer is a disease that can be prevented through lifestyle behaviors and 
recommended screenings. Risk factors for the development of colorectal cancer noted to be 
modifiable are: obesity, smoking, high consumption of red or processed meat, low fruit and 
vegetable intake, high alcohol intake, and low calcium intake (ACS, 2017). Some genetic 
conditions and chronic disease states may also predispose a person to colorectal cancer.  The 
American Cancer Society (2018) screening recommendations for early detection of colorectal 
cancer in average-risk asymptomatic patients begin at age 45 regardless of race or gender. This is 
a change from the recommendation of 50 years regardless of race or gender in previous years.  
Individuals with increased risk, such as family history of CRC, or symptoms such as abdominal 
pain, irregular or bloody bowel movements may be screened earlier than age 50 (See Appendix 
B). The five currently available screening tests include; fecal occult blood testing (FOBT), stool 
DNA test, flexible Sigmoidoscopy (FSIG), double contrast barium enema, colonoscopy or CT 
colonography (US Task Preventative Task Force, 2016). However, direct endoscopy is still the 
most accurate for visualization and removal of pre-cancerous polyps (Blumenthal, et.al, 2010).   
Screenings at the earliest recommended times have been associated with decreased 
mortality across all races and genders. Regardless of the risk or patient history, colorectal 
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screening that can detect and remove polyps is the best method of cancer prevention (ACS, 
2017).  Polyps are growths in the lining of the colon or rectum (National Institute of Diabetes 
and Digestive and Kidney Diseases, 2018). Not all polyps are cancerous, however, some may 
become cancerous over time. Therefore, undergoing a colonoscopy or flexible sigmoidoscopy to 
identify and remove polyps is critical for preventing cancer (NIDDK, 2018). 
The United States Department of Health and Human Services set forth a healthy people 
2020 initiative in which objective C-1 is to reduce the overall cancer rate (Healthypeople.gov, 
2016). A goal within the objective is to assess understanding of information patients received 
from their health care providers.  Provider recommendation continues to positively influence 
completion of CRC screening (Reiter & Linnan, 2011).  However, recommendations alone have 
not been as effective in increasing overall screening rates among African American women 
(Reiter & Linnan, 2011).  
Practice decision aids are tools used to help patients understand risk of disease (e.g. 
cancer development), provide options available for screening and time intervals for screening in 
the context of the patient’s preference for an outcome (Jimbo et. al, 2013).  Decision aids should 
also include the choice of not getting screened. The decision aid is designed to complement the 
discussion with the health care provider regarding a particular cancer screening (Jimbo et. al, 
2013). Some examples of decision aids currently available on CRC screening can be found at 
https://ncbi.nlm.nih.gov/pmc/articles/PMC3644368/ 
In a meta -analysis conducted on patient decision aids for colorectal cancer screening, 
patients in the decision aid group expressed greater intention to be screened and were 1.3 times 
more likely to complete screening at 16-52 weeks compared with patient in control groups 
(Volk, et al., 2016). Despite the evidence of the benefits of DAs for CRC screening, the use of 
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DAs in minority populations has received little attention. One systematic review on the use of 
decision aids with minority populations had a small body of evidence supporting the use of DAs 
in African Americans and the DA were not specific to CRC. Of the 22 articles included in the 
review, only 10 were tailored or customized for ethnic, sexual or racial differences (Nathan, et.al, 
2016). Despite this, researchers concluded that DA’s could be effective at improving screenings 
within minority populations (Nathan, et.al. 2016).  
Despite African American women being at high risk of CRC and having low screening 
rates, there is an absence of culturally targeted decision aids on CRC screening to address their 
needs and preferences.  This presents a potential barrier to effective communication and 
decisions to agree to CRC screening.  
 Provider recommendation is a positive indicator in completion of CRC screening (Reiter 
& Linnan, 2011, Nathan, et.al, 2016).  Identifying ways to better provide education and 
encouragement for preventative screenings can reduce the mortality and morbidity of a 
preventable disease process. As a diverse nation, implementing decisions aids in primary care 
settings that are more age, gender and culturally targeted may improve screening in populations 
that otherwise would continue to suffer disparities in mortality and morbidity from conditions 
such as CRC. The population of interest for the proposed project is African American women 
ages 45-75 years, since they continue to lag behind on improvement of colorectal cancer 
screening rates. 
Primary care providers in family and internal medicine care settings have the unique 
opportunity to promote preventative health to patients.  These providers can discuss how best to 
prevent disease and improve the quality of patient health.  As care providers, patients rely on 
providers’ quality of knowledge, care and recommendations of good health practice. Nurse 
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practitioner roles also incorporate aspects of nursing such as patient advocacy and holistic care.  
The literature review regards provider recommendation as an effective way to improve CRC 
screening among African American women (Bazargan, et.al, 2015, Reiter & Linnan, 2011).  
Along with provider recommendation, evidence -based medicine and shared decision-
making (SDM) are crucial parts of quality health care (Hoffman, Montori & Mar, 2014).  Shared 
decision making is “the process of clinician and patient jointly participating in a health decision 
after discussing the options, the benefits and harms and considering the patient’s values, 
preferences and circumstances (Hoffman, et. Al, 2014). [See Appendix B] Providers in primary 
care settings are also responsible for promoting health improvement, patient empowerment and 
education. In the SDM process, providers present patients with information about benefits and 
harms of alternative options and help them with decisions for screenings that also support the 
patient personal values (Hoffman, R. et. al, 2014). By incorporating SDM in patient encounters, 
education and CRC screening discussion may be improved. (Hoffman, R. et al, 2014).  
 
 
FIGURE 1: The Connection Between Evidence-Based Medicine and Shared 
Decision Making Adapted From: Hoffmann TC, Montori VM, Del Mar C. The Connection Between Evidence-
Based Medicine and Shared Decision Making. JAMA. 2014;312(13):1295–1296. doi:10.1001/jama.2014.10186 
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  Provider recommendation alone has not improved overall CRC screening rates in 
African American women. Specific concerns should acknowledge variables specific to African 
American women that can negatively affect screening, when deciding on education materials and 
teaching methods.  It has been noted in the literature that more effective, culturally targeted 
teaching is needed (Hoffman, et. al, 2017, Nathan, et al, 2016).  The goal of this Doctor of 
Nursing Practice project is to utilize the recommendations in the literature to develop culturally 
tailored education materials for African American women in regards to CRC screening. 
Clinical Question 
 In African American women age 45-75 years (P) how does the use of a culturally 
targeted decision aid in combination with provider recommendation (I) compare to provider 
recommendation alone (C) in improving intention to complete CRC screening (O)?  
The population (P) of interest is African American women ages 45-75 years.  The intervention 
(I) is provider recommendation for CRC screening along with a culturally targeted decision aid. 
The comparison (C) is provider recommendation CRC screening alone, without the decision aid. 
The outcome (O) to be measured is intention to complete CRC screening.  
The expected outcome is that the addition of the culturally targeted decision aid will 
increase intentions to complete CRC screening among AA women. The long-term outcome is 
that adherence to recommended screenings is expected to improve overall mortality and 
morbidity from CRC among AA women.  If this tool is shown to increase intention to complete 
CRC screening it will support the evidence for the use of decision aids, and may provide an 
option for other practitioners to implement in practice.  
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Review of Literature 
Search Strategy 
A systematic search of the literature was conducted to identify interventions designed to 
increase CRC screening in African American women and to determine factors that influence and 
interventions that improve CRC screening in African American women. Searches were 
conducted in the following databases: CINHAL, MEDLINE, COCHRANE review, PUB MED, 
and Psychology and Behavioral Sciences collection.  Key terms for the original search were 
African American, women, colorectal cancer, screening and cultural.  The search was narrowed 
to articles that were peer reviewed, published within the last ten years (2007-2017), performed 
within the United States and in English. Up To Date was also included but did not yield scholarly 
articles that were included in the review. Types of evidence included were systematic reviews, 
quantitative studies, qualitative studies, clinical practice guidelines, correlational analysis and 
educational decision aid. The exception to the search criteria was made for articles that were 
used to aide in evaluating the literature, or for research that may be foundational findings to 
support the research. 
Search Results 
The search criteria not including the word “cultural” and excluding the date yielded 
174,240 articles. Including the word cultural and limiting to articles within 10 years narrowed 
articles fitting the criteria to 44 articles. Thirty articles were excluded for not pertaining directly 
to African American women and colorectal cancer. Four articles could not be obtained 
electronically for review within the time frame indicated. Ten articles were selected to include in 
the evidence (See Appendix A- Evidence Matrix). 
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 The Evidence Hierarchy of designs was used to identify the level of evidence for each 
article. (Polit & Beck, 2017).  Using the evidence matrix, articles included, level II randomized 
clinical trials, level III systematic review of correlational or observational studies, Level IV 
single correlational/observational studies, and levels V and VI, which includes qualitative 
research studies. Appraisal of the literature was also done using the ten-question Critical 
Appraisal Skills Programme (CASP) tool for appraising qualitative research and systematic 
reviews (CASP, 2017). The CASP appraisal tool uses a 10-question questionnaire to determine 
how robust the study is and if it can be beneficial for future use.  For the qualitative studies 
included in the evidence base, the CASP tool was used to assess rigor, credibility and relevance. 
This was used to determine the articles suitability for inclusion in the evidence matrix. The 
following studies were selected for discussion as they represent the ten articles that were 
included in the review.  
Synthesis of the Evidence 
There are few examples of culturally targeted decision aids currently being consistently 
used in primary care settings.  For the seven studies that explored factors that influence CRC 
screening among African Americans the consistencies found were barriers to timely CRC 
screening, financial/cost, lack of knowledge, lack of perceived benefit and fear of CRC 
screening. Sociocultural factors also considered barriers to improving screening were lack of 
culturally targeted information, medical mistrust and group susceptibility, underutilization of 
information sources about health from media and Internet and a perception of low risk of CRC 
cancer among African Americans (Hoffman, et.al, 2017). Perceived benefits of early detection 
was associated with cancer knowledge and discussion with primary care provider (Bazargan, 
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et.al, 2015, Purnell et.al, 2009). Relevance of empowerment, privacy and collectivism and 
understanding mistrust are all barriers to screening (Purnell, et. al, 2009). 
Although there is limited literature on the use of DA to promote CRC screening among 
African American women, the existing literature suggests that DAs may be useful in practice and 
the literature on factors that influence CRC screening decisions can provide direction for 
designing culturally targeted DA for this high-risk group.  
Interventions to Increase CRC Screening 
Three interventions using DAs to promote screening among African Americans were 
identified. The first study, a randomized controlled trial published in Cancer provided an 
example of cultural decision aides (Hoffman, et. al, 2017).  Researchers utilized a conceptual 
framework of colorectal cancer screening decisions. In the study 89 African American 
participants aged 49-75 years were randomized to view a control video about hypertension or a 
decision aid video of culturally tailored CRC screening options and theory -based support in 
decisions in an educational entertainment format. Patients were recruited from internal medicine 
and family practice clinics, with diverse economic and cultural populations from November 2012 
to June 2013.  The authors concluded that viewing the entertainment CRC decision aide 
significantly increased screening knowledge, decreased decisional conflict and improved self -
advocacy. However, more participants in the control group actually completed the screening than 
the intervention group.  
In the second randomized clinical trial, three interventions intended to promote colorectal 
cancer screening in African Americans were tested (Blumenthal, et.al, 2010). The three 
interventions were group education, one-on-one education and financial support. The outcome of 
the study was that the cohort receiving group education had a significant increase in knowledge 
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of CRC screening.  They also had statistically significant increases in completion of CRC 
screening compared to the financial support group. However, that only ended up being 33% of 
the 259 participants.  Limitations of the study included significant attrition for participants over 
the six-month time frame of the study completion. More than 40% of participants did not 
complete the study. 
Phillip, Duhmael, & Jandorf conducted a study to evaluate the impact of an educational 
intervention to increase CRC screening rates in the African American Community (2010).  The 
study noted there were a few interventions designed that address CRC screening behavior in 
underserved or diverse communities, including the African American community.  The study 
consisted of 118 African American participants from two primary care sites in New York.  The 
majority of the participants were women (75.4%).  Participants received printed materials on 
CRC screening.  They either received a standard brochure or a brochure developed and designed 
by the authors.  The materials created by the authors were culturally targeted and provided 
information on types of screening for CRC with emphasis on colonoscopy. Of the participants 
who completed screenings, 25% reported significant reduction in fatalistic beliefs and increase in 
decisional balance.  
Factors that Influence CRC Screening 
Learning the behavior of any population is prudent when examining how to improve 
adherence to a behavior. The same is true for African American women’s CRC screening 
behavior. The following studies involve exploring social or cultural constructs affecting 
willingness to complete CRC screening.   
In a qualitative study using focus groups of African Americans that explore factors that 
influence screening habits for colorectal cancer screening, (May et. al, 2016) participants of the 
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study listed how they receive information best and what would influence their behavior.  
Participants noted they receive information from medical staff and media outlets. Group 
participants had a positive reaction to the use of African American celebrities or community 
figures to endorse screening, improve awareness and promote timely screening. The findings 
should be interpreted with caution, as sample size was small. However, in a society that is so 
driven by social media the author feels that appropriate culturally targeted and entertainment- 
based ads may hold promise for improving CRC screening rates among African American 
women.   
A cross sectional study by Patel and colleagues (2011), looked at factors that influenced 
CRC screening in low income African Americas in Tennessee. Participants ages 50 years and 
older were selected from a database from Meharry CNP community survey database. The study 
was conducted in three cities in West, East and Middle Tennessee and included a sample of 460 
men and women. Participants in the study had lower screening rates for CRC (35%) compared to 
African Americans in the state of Tennessee (59%).  An explanation may be that the participants 
did not have the resources or health insurance in order to receive appropriate screening. Factors 
reported, as barriers to screening included cost, time, transportation, where to get screening and 
fear of finding cancer. These did vary by geographic region. Predictors of completing screening 
were being married and having health insurance.  Information about predictors to screening, 
obstacles, demographics and lifestyle predictors to screening should be incorporated into 
education for improving CRC screening rates.  
In a study by Reiter & Linnan (2011) results of a survey given to African American 
women noted women who reported a recent Pap smear test were likely to be current on 
mammography, and those that had current mammography were more likely to be within 
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recommended guidelines for CRC screening. This finding suggest that women who screen for 
one form of cancer may be more likely to screen for other forms of cancer.  The most frequently 
reported barriers were, lack of knowledge of test, lack of physician recommendation, not 
knowing when to have test, lack of interest in getting test, worrying about screening results, 
belief of test being painful or embarrassing and lack of cancer history of family members. The 
study noted that 94% of the women involved in the study completed Pap smear testing, 70% 
completed mammograms and 64% completed CRC screening.  Correlational studies are not 
classified as high levels of evidence. However, this study does give insight to the behaviors of 
African American women in regards to cancer screenings in general with CRC screening being 
the lowest.  
 A study exploring social and cultural factors related to African Americans perceptions 
on colorectal cancer screening was conducted (Purnell, et al, 2009). The study included 198 
participants age 45 years or older (n=198).  A cross sectional study was conducted among twelve 
social groups (fraternities). The study explored variables that contribute to lack of CRC 
screening in African Americans.  The focus was on medical mistrust, physician ethnicity, group 
susceptibility, and traditional strategies.  Outcomes of the study suggested perceived benefit and 
intent are highest in African Americans within a group. Those likely to screen had less mistrust 
of the medical system, high traditional cultural orientation and had an African American 
physician (Purnell et. al, 2009). It will be important to consider social as well as cultural 
variables to proceed with the best level of education materials.   
A study consisting of 513 African American women from 11 churches explored the 
perceived benefits of early cancer detection, in Los Angeles. Researchers concluded that 74% of 
study participants believed the chances for survival of early detection of breast cancer survival 
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were good, whereas, only 52% felt the same for cervical cancer and only 51% for colorectal 
cancer (Bazargan et. al, 2015). The perceived benefit of early cancer detection was associated 
with having had a discussion of risk with a doctor and of having higher cancer knowledge. 
Perceived benefit was a positive predictor of completing screening. Creating programs that 
increase knowledge of colorectal cancer and discussions that focus on risk education, may have a 
positive effect on intention to complete screening. One of the limitations of the study was, non-
random sampling.  It may not, be representative of all African American women in Los Angeles 
due to the small sample size. Nonetheless, the study may be useful in confirming physician 
impact on screening and tailoring information to include perceived benefits. 
To continue with the social cultural constructs relevant to African American CRC 
screening, the author located a study in Psychology, Health and Medicine Journal (Thompson, 
Harris, Clark, Purnell & Deshpande, 2015). A total of 1,021 African-Americans participated in 
the telephone survey to assess sociocultural attitudes regarding CRC screening (Thompson, et.al, 
2015).  Confirmatory factor analysis was performed to determine the perceived benefits and 
barriers to CRC screening. The three sociocultural constructs that showed significantly 
contributed to CRC screening were empowerment, collectivism and privacy.  The importance of 
this study for future interventions regarding CRC screening is to consider empowerment and 
privacy concerns for African Americans in regards to CRC screening.  Using findings from a 
psychology study within a nursing research project adds dimension and quality to the social and 
cultural components of the research.  
The highest level of evidence according to the hierarchy of evidence (Polit and Beck, 
2017) is the metanalysis of randomized clinical trials. The author was able to locate one 
systematic review of literature exploring persistent underuse of colon cancer screening in African 
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Americans (Bromley, Folasade, Federer, Spiegel, and Van Oijen, 2015).  A conceptual 
framework was also included in the review identifying barriers to colonoscopic screening. 
Nineteen studies met the inclusion criteria and were included in the systematic review. The 
results were consistent with other findings noted within the literature.  Barriers to screening 
included fear, lack of knowledge of CRC risk and low perceived benefit.  It also included factors 
such as failure of provider to recommend and lack of provider knowledge of screening. Less 
influential barriers were financial, no consistent primary care and lack of insurance (Bromley et. 
al, 2015).   
Appraisal of the Overall Evidence 
 The ten articles reviewed were comprised of diverse strategies to determine how 
to improve CRC screening among AAs. The overall quality of the articles reviewed was 
moderate considering there was only one systematic review and two randomized clinical trials 
included. A consistent limitation was small sample size across studies.  Another limitation was 
attrition. However, the use and impact of educational interventions that address the perceived 
barriers, risk and benefits as noted within the literature review may be useful in designing 
education materials for AA women.  
Conceptual Framework 
Key Concepts 
In addressing the clinical question regarding improving CRC screening among African 
American women, one should investigate conceptual frameworks that can be used to guide 
practice improvement. Many conceptual frameworks exist in healthcare to support various types 
of research.  The focus of the clinical question is whether a culturally targeted DA can improve 
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intention to complete CRC screening in African American women.  In order to improve 
screening rates, the provider must understand what barriers the patient may be experiencing.  
The Health Belief Model (HBM) explores how personal beliefs influence health 
behaviors (Petiparin, 2016). The Health Belief Model is widely used in nursing and in 
preventative health study (Polit & Beck, 2016). The model was originally created by social 
psychologist in the 1950’s Hochbaum, Rosenstock, and Kegel (1974). It was derived from the U. 
S. Public Health Service questioning why a free health screening for tuberculosis had not been 
successful (Rosenstock, 1974).   
Four major constructs of the HBM are: perceived susceptibility, perceived seriousness, 
perceived benefits and perceived barriers (Polit and Beck, 2016). Perceived susceptibility is how 
likely a person believes a condition will occur or affect them.  The greater the perceived 
susceptibility of a disease (CRC), the more likely a person will do something to prevent it 
(Petiparin, 2016). Perceived seriousness is a person’s belief about how severe or debilitating an 
illness or disease (CRC) may be (Petiparin, 2016). Perceived barriers are things that a person 
views as obstacles to performing a particular task. These can include cost, time and complexity 
(Polit & Beck, 2016).  Perceived benefits are favorable outcomes an individual expects to occur 
if a behavior is completed in response to the threat of an illness or disease state. The constructs 
may occur individually or simultaneously to explain and predict health behavior.  
Application 
The HBM has been used in prior research promoting CRC screening.  A secondary 
observational analysis of data from an RCT was conducted to test a CRC intervention based on 
factors from an Expanded Health Belief Model (Sohler, Jerant, Franks, 2015).  The goal of the 
intervention was to encourage and improve CRC screening rates, however it did not have the 
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desired changes in improving screening behavior.  Their research noted five independent factors 
instead of all of the constructs of the theory simultaneously.  These factors were screening 
knowledge, self- efficacy, barriers, and stage of readiness and discussion with a provider with 
CRC screening after one year. Sohler et. al, (2015) looked at why interventions had not been 
successful in an effort to improve interventions in the future. The one-year follow up results 
showed that self -efficacy, readiness and discussion with a healthcare provider were positive 
predictors of completing screening (Sohler, et. al, 2015). Researchers concluded that there is 
value in the provider discussion and supplementing patients with materials and interventions that 
are HBM based may be promising for improving CRC screening (Sohler, et. al, 2015). The focus 
of the study was not African American females but the results may translate into utilizing the 
HBM more effectively for further work within the DNP project.  
The Health Belief Model served as the framework for answering the project clinical 
question regarding African American women and CRC screening.  Women who perceive high 
susceptibility and seriousness for CRC, perceive few barriers and high benefits to CRC screening 
will more likely have intentions to complete CRC screening. The goal of the decision aid is to 
improve those perceptions and beliefs. This is consistent with the goal of shared decision 
making.  
A self reported participant pre and post survey was used in order to gauge participants’ 
level of susceptibility, seriousness, barriers and benefits to CRC screening in the DNP project. 
The student investigator for the purpose of the DNP project developed the survey. The self 
reported response to the statement; “Colorectal cancer is rare among African Americans” was 
designed to assess the participant level of susceptibility.  To gauge the perceived level of 
seriousness participants responded to the statement, “ I am at risk of becoming ill or dying from 
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colorectal cancer”. Using information found in the literature on common barriers for screening, 
participants were asked to respond the statements “I can’t take off from work to have the 
colorectal cancer screening done”, “The screening for colorectal cancer cost too much” and “I 
am uncomfortable with the bowel prep for the colorectal cancer screening.”  Benefits of 
screening were assessed when participants responded the statement “Colorectal cancer death is 
preventable through screening”.  
The DNP project focused on intervening on barriers of CRC screening in order to 
improve health outcomes. By introducing a more culturally appropriate, targeted decision aide as 
opposed to provider recommendation only, the hope was to improve knowledge of susceptibility 
and seriousness to influence screening.  
Methodology 
Project Implementation  
The Institutional Review Board (IRB) of Georgia State University granted approval for 
this project.  
 Setting 
 The project location is a primary care practice located in the United States.  The location 
is within11 miles southeast of a metropolitan area. The population of recruitment is 86,261 
where 39.7% are white, 37.6% are black and 16.7% are Hispanic (Bestplaces.net, 2018).  
The family practice provides primary care services to men, women, children and newborns. They 
provide treatments and care for a variety of conditions including dermatology, orthopedic joint 
injections, immunizations and well woman exams.  The clinic has 14 patient treatment rooms, an 
in-house lab, and an in-house radiology room.  The full time staff includes a physician, two nurse 
practitioners, several medical assistants, front office staff and an in-house manager. Once a week 
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a cardiologist and a general surgeon are on site to evaluate patients. The clinic accepts all forms 
of commercial insurance, Medicare, and one provider accepts Medicaid.  
Subjects 
 The target sample size was 30 AA women receiving primary care at the family practice 
clinic.  Convenience sampling was used to recruit 21 AA women receiving primary care at the 
family practice.  Inclusion criteria were women ages 45-75 years of age who were English 
speaking, identified as AA and were naïve to colorectal cancer screening or refuse further 
screening.  Exclusion criteria were outside of age 45-75, non-African American, male and non- 
English speaking. Participants were identified by the primary care provider as being female and 
within the criteria age of 45-75.  
Instrument/Tools 
The instrument used to evaluate intention to complete colorectal cancer screening is a pre 
and post survey the author developed.  The survey consisted of 8 items. The responses were in a 
5-point Likert Scale (1 = Strongly Disagree and 5=Strongly Agree). The eight items where 
summed to gain a total score, which ranged from 8-40. Higher scores indicated greater intention 
to complete CRC screening. The tool was administered in paper and pencil format.  It took 
participants approximately 10 minutes to complete both pre and post surveys. The tool was 
reviewed and deemed acceptable by the project faculty. Reliability of the specific tool is 
unknown to date. Use of the tool in the population of interest warrants a reliability analysis upon 
data completion.  
The outcome measures are the numeric values derived from the pre and post survey scale. 
The Survey scores are obtained after the participant selects the numeric value that corresponds to 
the statement they choose. (See Appendix C) The scores totals for each question where summed 
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and converted to a percentage of total responses. The means of each question where also 
obtained.  A total mean score for all of the pre-test scores and the post-test scores where 
obtained.  
Intervention  
 The DA is a student investigator developed five-page color pamphlet that provides 
statistics on CRC. The DA explains with CRC is and provides information on different types of 
CRC screening options available. It includes a contact number and website where more 
information may be obtained. The pamphlet includes photos of AA women and information 
specific to them.  The information contained in the pamphlet was obtained from the Centers for 
Disease Control (CDC) campaign entitled; Colorectal cancer screening saves lives (2017). 
[See Appendix E] 
Data Collection 
 Data collection was done on paper and stored without patient identifiers in a folder until 
the end of the project. The folder is secured in a locked office. Potential participants fitting the 
inclusion criteria were identified by the primary care provider through documentation in the 
medical record being between the age of 45-75 and female.  As patients were escorted to their 
rooms for their appointments they were asked if they would be interested in participating and 
consented by the student investigator. The student investigator had no access to patient records, 
demographic or personal information for use in the study.  The study was completed while 
waiting in the exam room with the door closed. The only demographic information collected was 
patient age. 
A packet containing the consent, pre-survey, decision aid and post-survey were given to 
participants who agreed to participate in the study. An initial survey consisting of eight questions 
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regarding intention to complete CRC screening derived, from the HBM, was given to the 
participants.  Consent and instructions for completing the survey contained the statement “Your 
health care provider has recommenced a screening for colorectal cancer.” Participants were 
asked to complete the pre-survey while in the medical office.  
The participants then viewed the included DA. Following viewing the DA, participants 
were asked to complete a post intervention survey containing the same eight questions they had 
been asked on the pre-survey.  The participants then placed all study materials back in the packet 
signaling the end of the participation in the study.  Participants then received a $5 gift card to 
Starbucks for participating in the project. The packet was then collected and securely stored by 
the student investigator. 
Analysis 
The student leader conducted the analysis using the IBM Statistical Package for the 
Social Sciences (SPSS) software version 24. Descriptive statistics were used to summarize the 
findings. DNP committee members were consulted for appropriateness of the statistical test and 
review of the results for accuracy. Due to a small sample size, a Wilcoxon Matched pairs (Signed 
rank) test was conducted to evaluate the impact of the culturally targeted decision aid 
intervention on African American women’s intention to complete colorectal cancer screening. 
The sum scores for the pre intervention survey were compared to the sum scores for the post 
intervention surveys.  
Results 
A total of 21 African American women ranging in ages from 47-69 participated in the 
study. The mean age of participants was 57.24 (SD= 7.09). 
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Participants’ responses to the pre-intervention (DA) and post-intervention (DA) Survey 
are presented in Table 2. The post survey responses are in red. 
 
Table 2: Participants’ response to the Pre intervention (DA) and Post Intervention (DA) 
  Strongly 
Disagree 
(1) 
Somewhat 
Disagree (2) 
Neither 
Disagree nor 
Agree (3) 
Agree 
(4) 
Strongly 
Agree 
(5) 
1 I am at risk of becoming ill or dying from 
colorectal cancer. (PRE) 
 
I am at risk of becoming ill or dying from 
colorectal cancer. (POST) 
 
 
52.4% 
 
 
33.3% 
4.8% 
 
 
9.5% 
23.8% 
 
 
23.8% 
14.3% 
 
 
23.8% 
4.8% 
 
 
9.5% 
2 Colorectal cancer death is preventable 
through screening (PRE) 
 
Colorectal cancer death is preventable 
through screening (POST) 
 
 
0% 
 
 
0% 
14.3% 
 
 
0% 
4.8% 
 
 
9.5% 
23.8% 
 
 
28.6% 
57.1% 
 
 
61.9% 
3 I am afraid of having the screening test for 
colorectal cancer. (PRE) 
 
I am afraid of having the screening test for 
colorectal cancer.(POST) 
57.1% 
 
 
52.4% 
4.8% 
 
 
9.5% 
23.8% 
 
 
9.5% 
9.5% 
 
 
19.0% 
4.8% 
 
 
9.5% 
4 Colorectal cancer is rare among African 
Americans (PRE) 
 
Colorectal cancer is rare among African 
Americans (POST) 
 
52.4% 
 
 
61.9% 
14.3% 
 
 
14.3% 
19% 
 
 
14.3% 
4.8% 
 
 
4.8% 
4.8% 
 
 
4.8% 
5 I plan to complete the screening for 
colorectal cancer as recommended (PRE) 
 
I plan to complete the screening for 
colorectal cancer as recommended (POST) 
 
9.5% 
 
 
0% 
4.8% 
 
 
9.5% 
23.8% 
 
 
4.8% 
23.8% 
 
 
42.9% 
38.1% 
 
 
42.9% 
6 I can’t take off from work to have the 
colorectal cancer screening done. (PRE) 
 
I can’t take off from work to have the 
colorectal cancer screening done. (POST) 
 
57.1% 
 
 
57.1% 
4.8% 
 
 
4.8% 
19.0% 
 
 
23.8% 
14.3% 
 
 
9.5% 
4.8% 
 
 
4.8% 
7 The screening for colorectal cancer cost too 
much. (PRE) 
 
The screening for colorectal cancer cost too 
much. (POST) 
 
38.1% 
 
 
47.6% 
4.8% 
 
 
0% 
42.9% 
 
 
42.9% 
9.5% 
 
 
4.8% 
4.8% 
 
 
4.8% 
CULTURALLY TARGETED DECISION AID   
 
27 
 
8 
 
I am uncomfortable with the bowel prep for 
the colorectal cancer screening. (PRE) 
 
I am uncomfortable with the bowel prep for 
the colorectal cancer screening. (POST) 
 
9.5% 
 
 
23.8% 
 
23.8% 
 
 
33.3% 
 
28.6% 
 
 
19.0% 
 
33.3% 
 
 
19.0% 
 
4.8% 
 
 
4.8% 
 
 
The author’s null hypothesis is: Ho= In AA women age 45-75 there was no improvement 
of intention to complete CRC screening with decision aid use and provider recommendation 
compared to provider recommendation alone. The alternative to the null is Ha= In AA women 
ages 45-75 there is improvement of intention to complete CRC screening with decision aide use 
and provider recommendation compared to provider recommendation alone.  The variables are 
the before survey responses (v1) and the after survey responses (v2). The author has chosen a 
significance value (a) where a= 0.05.  
 The mean score of the pre test survey was 2.685 with standard deviation 1.28. The mean 
score of post-test survey was 2.762 with a standard deviation of 1.18. The results of the 
Wilcoxon (Signed Ranks) test showed level of intention to complete screening did not differ 
significantly from the pre (M rank=8.44) to the post intervention group (M rank=9.50) where the 
sum of the ranks was 67.50 and 85.50 respectively and z=. 666. 
Discussion 
 The study results of this DNP project do not suggest that the use of culturally targeted 
decision aids have a greater impact on influencing intention to complete colorectal cancer 
screening among African American women. With a p value of .05 we must accept the null 
hypothesis as stated Ho= In 21 AA women ages 45-75 there is no improvement of intention to 
complete CRC screening with decision aid use and provider recommendation compared to 
provider recommendation alone. However, there where significant findings from the survey that 
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suggest further research with a larger sample should be performed to truly assess the value of the 
DA.  
 Prior to viewing the decision aid 61.9% of patients planned to complete a CRC screening. 
After viewing the DA 85.8% of participants planned to complete the screening.  Also perceived 
benefit of screening did slightly improve after patients viewed the decision aid.  In this sample, 
the majority of participants where aware that CRC is preventable through early screening. 
Though most patient understood that CRC is not rare among African Americans those that where 
not sure responding Neither Disagree nor agree reduced from 19% to 14.3% after viewing the 
decision aid.  
  The study did not show statistical significance in intention to complete screening; it did 
seem to increase knowledge of colorectal cancer screening. These results are similar to a 
randomized controlled trial conducted by Hoffman, et.al, in which an entertainment-education 
colorectal cancer screening decision aid for African American’s was used and showed great 
promise (2017).  In the study 89 participants were randomized into a decision aid video that 
contained culturally tailored information about colorectal cancer screening options and a control 
group video about hypertension. Viewing the decision aid significantly increased knowledge of 
colorectal cancer screening, decreased decisional conflict, and improved self-efficacy.  However, 
the study showed no significant difference in participant attitudes, norms or intentions (Hoffman, 
et.al, 2017).  On three month follow up only 23% of participants had completed a colonoscopy. 
(Hoffman, et.al, 2017). 
 Unexpected findings from the study were that patients did not seem to know cost of the 
test. This is unlike a prior study by Patel, 2011 where cost was listed as a barrier.  However, it 
was consistent with a met analysis of 19 randomized clinical trials where financial barriers were 
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less influential in screening behavior (Bromley, et. al, 2015). This may be based on whether the 
patient has insurance that will greatly reduce the cost of the screening.  Also, the DA did not 
include specific information on cost of the screening.  Nearly half 42.9% of participants pre and 
post intervention neither agreed or nor disagreed that the screening might cost too much.  
 The ability to take off from work to have the screening performed did not appear to be a 
barrier to CRC screening for most of the study participants (62%). This did not change from the 
pre to the post intervention. Other screening barriers are lack of knowledge of CRC risk and low 
perceived benefit (Bromley, et. al, 2015). The study had similar findings.  Prior to viewing the 
DA, 52.4% of participants strongly disagreed to the statement “I am at risk of becoming ill or 
dying from colorectal cancer”. After viewing the DA, only 33.3% of participants strongly 
disagreed to the same statement.  Similarly to the study by Hoffman in 2017, viewing the study 
DA did seem to increase knowledge of CRC screening. Interestingly, patients reported less 
discomfort with the bowel prep for the CRC screening after viewing the DA than before viewing 
it.   
Limitations 
 A major study limitation was the small sample size of 21.  Using a different method to 
recruit participants and conducting the study over a longer period of time could help eliminate 
this limitation.  Also, the study had no follow up with participants in order to determine if they 
completed screening in the future. The study was also conducted at one primary care office. 
Future research should include a larger sample size and may be benefited by using several 
primary care offices in the area.  
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Practice Implications 
 Colorectal cancer is the third leading cause of cancer related death in the United States is 
preventable through early screening (ACS, 2017). Due to a lack of early screening, AA men and 
women are more likely to develop colorectal cancer at a younger age and be at more advanced 
stages when diagnosed (Hall, 2017). Though overall incidence has declined in the last decade, 
the incidence of mortality is highest among AAs (Hall, 2017). Addressing social issues including 
lack of access and bringing awareness to the AA community about CRC screening is imperative 
to reduce the morbidity and mortality of a preventable disease through early screening. More 
research is needed on effective methods to bring awareness to CRC through the use of DA 
specifically targeting high-risk populations such as AA women.  
 The use of DA’s has shown to be effective at increasing knowledge, reducing decisional 
conflict and reduction in fatalistic beliefs (Phillip et. al, 2010, Hoffman, et. al, 2017). Cultural 
considerations in teaching methods targeting populations at risk for morbidity and mortality of 
disease is imperative in improving screening behaviors. The use of survey’s similar to the one 
used in this study in practice can be beneficial to understanding the patient beliefs about CRC 
screening.  It may also promote a better decision on barriers to screening. APRNs should 
consider incorporating DA’s into the process of recommending CRC screening for AA women 
as a time saving method and to enhance the shared decision making process.  
Implications for policy on CRC screening have already begun to make adjustments to 
improve performing screening at the earliest recommended times.  The current recommendations 
from the ACS are to begin screenings at age 45 regardless of family history or suspected risk 
(2018) in response to CRC prevalence in a younger population. In 2009, this same 
recommendation was made by the American College of Gastroenterology that all AA’s begin 
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screening at age 45 in an effort compensate for low screening rates (ACG, 2009). The majorities 
of studies found in the literature were small and did not focus on AA women and CRC screening.  
Conclusion 
AA women show interest in learning about CRC screening as evidence by their 
participation and completion of the project. Although a statistically significant difference in CRC 
screening intentions was not found, there is clinical significance in the percent changes from 
agree to disagree. The culturally targeted DA showed promise for improving knowledge of CRC 
screening and may help to initiate provider-patient discussions. Future research should include 
larger studies with follow up and focus on why increasing knowledge and decreasing decisional 
conflict about CRC screening does not equate to improved screening behavior among AA 
women. 
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APPENDIX B 
 
American Cancer Society Guidelines on Screening and Surveillance for the Early Detection 
of Colorectal Adenomas and Cancer in People at Increased Risk or High Risk 
INCREASED RISK – People who have a history of polyps on prior colonoscopy 
Risk category When to test Recommended 
test(s) 
Comment 
People with small 
rectal hyperplastic 
polyps 
Same age as those 
at average risk 
Colonoscopy, or 
other screening 
options at same 
intervals as for 
those at average 
risk 
Those with hyperplastic 
polyposis syndrome are at 
increased risk for 
adenomatous polyps and 
cancer and should have 
more intensive follow-up. 
People with 1 or 2 
small (no more than 1 
cm) tubular 
adenomas with low-
grade dysplasia 
5 to 10 years after 
the polyps are 
removed 
Colonoscopy Time between tests should 
be based on other factors 
such as prior colonoscopy 
findings, family history, 
and patient and doctor 
preferences. 
People with 3 to 10 
adenomas, or a large 
(at least 1 cm) 
adenoma, or any 
adenomas with high-
grade dysplasia or 
3 years after the 
polyps are 
removed 
Colonoscopy Adenomas must have 
been completely removed. 
If colonoscopy is normal 
or shows only 1 or 2 small 
tubular adenomas with 
low-grade dysplasia, 
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villous features future colonoscopies can 
be done every 5 years. 
People with more 
than 10 adenomas on 
a single exam 
Within 3 years 
after the polyps are 
removed 
Colonoscopy Doctor should consider 
possible genetic syndrome 
(such as FAP or Lynch 
syndrome). 
People with sessile 
adenomas that are 
removed in pieces 
2 to 6 months after 
adenoma removal 
Colonoscopy If entire adenoma has 
been removed, further 
testing should be based on 
doctor’s judgment. 
INCREASED RISK – People who have had colorectal cancer 
Risk category When to test Recommended 
test(s) 
Comment 
People diagnosed 
with colon or rectal 
cancer 
At time of 
colorectal surgery, 
or can be 3 to 6 
months later if 
person doesn’t 
have cancer spread 
that can’t be 
removed 
Colonoscopy to 
look at the entire 
colon and remove 
all polyps 
If the tumor presses on the 
colon/rectum and prevents 
colonoscopy, CT 
colonoscopy (with IV 
contrast) or DCBE may be 
done to look at the rest of 
the colon. 
People who have had 
colon or rectal cancer 
removed by surgery 
Within 1 year after 
cancer resection 
(or 1 year after 
colonoscopy to 
make sure the rest 
Colonoscopy If normal, repeat in 3 
years. If normal then, 
repeat test every 5 years. 
Time between tests may 
be shorter if polyps are 
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of the 
colon/rectum was 
clear) 
found or there’s reason to 
suspect Lynch syndrome. 
After low anterior 
resection for rectal cancer, 
exams of the rectum may 
be done every 3 to 6 
months for the first 2 to 3 
years to look for signs of 
recurrence. 
INCREASED RISK – People with a family history 
Risk category Age to start 
testing 
Recommended 
test(s) 
Comment 
Colorectal cancer or 
adenomatous polyps 
in any first-degree 
relative before age 
60, or in 2 or more 
first-degree relatives 
at any age (if not a 
hereditary 
syndrome). 
Age 40, or 10 
years before the 
youngest case in 
the immediate 
family, whichever 
is earlier 
Colonoscopy Every 5 years. 
Colorectal cancer or 
adenomatous polyps 
in any first-degree 
relative aged 60 or 
older, or in at least 2 
second-degree 
relatives at any age 
Age 40 Same test options 
as for those at 
average risk. 
Same test intervals as for 
those at average risk. 
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HIGH RISK 
Risk category Age to start 
testing 
Recommended 
test(s) 
Comment 
Familial adenomatous 
polyposis (FAP) 
diagnosed by genetic 
testing, or suspected 
FAP without genetic 
testing 
Age 10 to 12 Yearly flexible 
sigmoidoscopy to 
look for signs of 
FAP; counseling to 
consider genetic 
testing if it hasn’t 
been done 
If genetic test is positive, 
removal of colon 
(colectomy) should be 
considered. 
Lynch syndrome 
(hereditary non-
polyposis colon 
cancer or HNPCC), 
or at increased risk of 
Lynch syndrome 
based on family 
history without 
genetic testing 
Age 20 to 25 
years, or 10 years 
before the 
youngest case in 
the immediate 
family 
Colonoscopy every 
1 to 2 years; 
counseling to 
consider genetic 
testing if it hasn’t 
been done 
Genetic testing should be 
offered to first-degree 
relatives of people found 
to have Lynch syndrome 
mutations by genetic tests. 
It should also be offered if 
1 of the first 3 of the 
modified Bethesda criteria 
is met.* 
Inflammatory bowel 
disease: 
-Chronic ulcerative 
colitis 
-Crohn’s disease 
Cancer risk begins 
to be significant 8 
years after the 
onset of pan colitis 
(involvement of 
entire large 
intestine), or 12-15 
years after the 
onset of left-sided 
colitis 
Colonoscopy every 
1 to 2 years with 
biopsies for 
dysplasia 
These people are best 
referred to a center with 
experience in the 
surveillance and 
management of 
inflammatory bowel 
disease. 
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APPENDIX C 
Directions for participating in colorectal cancer screening study: 
• Your primary care provider has recommended you have a screening test for colorectal 
cancer. Please read the questions on the pre test and circle the number that best explains 
how you feel.   
• Please view the educational material included.  
• After you have viewed the educational material, please complete the post- test by circling 
the number that best explains how you feel.   
• By completing the pre and post survey you are agreeing to participate in the survey.   
• Please do not write your name, Date of birth or date on the survey.   
• Once you have completed the surveys place them in the large envelope provided for you. 
• You will receive a $5 gift card upon completion of the surveys.  
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APPENDIX D 
 
Age __________ 
 
CRC Screening Intention Pre and Post Survey 
 
  Strongly 
Disagree 
Somewhat 
Disagree 
Neither 
Disagree nor 
Agree  
Agree Strongly 
Agree 
1 I am at risk of becoming ill or dying from 
colorectal cancer. 
1 2 3 4 5 
2 Colorectal cancer death is preventable 
through screening. 
1 2 3 4 5 
3 I am afraid of having the screening test for 
colorectal cancer. 
1 2 3 4 5 
4 Colorectal cancer is rare among African 
Americans. 
1 2 3 4 5 
5 I plan to complete the screening for 
colorectal cancer as recommended. 
1 2 3 4 5 
6 I can’t take off from work to have the 
colorectal cancer screening done. 
1 2 3 4 5 
7 The screening for colorectal cancer cost too 
much. 
1 2 3 4 5 
8 I am uncomfortable with the bowel prep for 
the colorectal cancer screening. 
 
1 
 
2 
 
3 
 
4 
 
5 
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APPENDIX E 
 
CRC Decision Aid- Culturally Targeting AA Women 
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